Related references
Note: Only part of the references are listed.Pseudomonas aeruginosa Cytotoxins: Mechanisms of Cytotoxicity and Impact on Inflammatory Responses
Stephen J. Wood et al.
CELLS (2023)
Novel Genetic Discoveries in Primary Immunodeficiency Disorders
Margaret T. Redmond et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2022)
Therapeutic evaluation of immunomodulators in reducing surgical wound infection
Foyez Mahmud et al.
FASEB JOURNAL (2022)
Metabolic reprogramming of Pseudomonas aeruginosa by phage-based quorum sensing modulation
Hanne Hendrix et al.
CELL REPORTS (2022)
Overriding impaired FPR chemotaxis signaling in diabetic neutrophil stimulates infection control in murine diabetic wound
Ruchi Roy et al.
ELIFE (2022)
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2022)
IL-10 Dysregulation Underlies Chemokine Insufficiency, Delayed Macrophage Response, and Impaired Healing in Diabetic Wounds
Ruchi Roy et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
CrkII/Abl phosphorylation cascade is critical for NLRC4 inflammasome activity and is blocked by Pseudomonas aeruginosa ExoT
Mohamed F. Mohamed et al.
NATURE COMMUNICATIONS (2022)
Ceftazidime/Avibactam and Other Commonly Used Antibiotics Activity Against Enterobacterales and Pseudomonas aeruginosa Isolated in Poland in 2015-2019
Patrycja Zalas-Wiecek et al.
INFECTION AND DRUG RESISTANCE (2022)
Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection
T. Ferry et al.
NATURE COMMUNICATIONS (2022)
Frequency, Etiology, Mortality, Cost, and Prevention of Respiratory Tract Infections-Prospective, One Center Study
Wieslawa Duszynska et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Honey: An Advanced Antimicrobial and Wound Healing Biomaterial for Tissue Engineering Applications
Joel Yupanqui Mieles et al.
PHARMACEUTICS (2022)
Pseudomonas aeruginosa: Recent Advances in Vaccine Development
Matthew Killough et al.
VACCINES (2022)
Pseudomonas aeruginosa Infections in Cancer Patients
Paulina Paprocka et al.
PATHOGENS (2022)
Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance
Ioana-Andreea Lungu et al.
PHARMACEUTICS (2022)
Fluoroquinolone antibiotics: Occurrence, mode of action, resistance, environmental detection, and remediation-A comprehensive review
Sunidhi Bhatt et al.
ENVIRONMENTAL POLLUTION (2022)
Infectious keratitis: trends in microbiological and antibiotic sensitivity patterns
Mohammad Soleimani et al.
EYE (2021)
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
Elio Rossi et al.
NATURE REVIEWS MICROBIOLOGY (2021)
The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol
Yasaman Taheri et al.
FRONTIERS IN PHARMACOLOGY (2021)
Development of a Chimeric Vaccine Against Pseudomonas aeruginosa Based on the Th17-Stimulating Epitopes of PcrV and AmpC
Ying Wang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Comparison of Clinical Features and Treatment Outcomes of Pseudomonas aeruginosa Keratitis in Contact Lens and Non-Contact Lens Wearers
Rikki Enzor et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections
Young-A. Heo
DRUGS (2021)
Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets
Dragos Serban et al.
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS (2021)
Pseudomonas aeruginosa Ventilator-Associated Pneumonia Rabbit Model for Preclinical Drug Development
Nhu T. Q. Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Irene Jurado-Martin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Bioactive Antimicrobial Peptides as Therapeutic Agents for Infected Diabetic Foot Ulcers
Jessica Da Silva et al.
BIOMOLECULES (2021)
A Novel Use of Allopurinol as A Quorum-Sensing Inhibitor in Pseudomonas aeruginosa
Ahmed Al Saqr et al.
ANTIBIOTICS-BASEL (2021)
Dual transcriptional analysis reveals adaptation of host and pathogen to intracellular survival of Pseudomonas aeruginosa associated with urinary tract infection
Cristina Penaranda et al.
PLOS PATHOGENS (2021)
Distribution and drug resistance of pathogens in burn patients in China from 2006 to 2019
Hui Chen et al.
WORLD JOURNAL OF CLINICAL CASES (2021)
Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity
Peter S. Steyger
AMERICAN JOURNAL OF AUDIOLOGY (2021)
Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa
George L. Daikos et al.
ANTIBIOTICS-BASEL (2021)
THERAPEUTIC ASSESSMENT OF N-FORMYL-METHIONYL-LEUCYL- PHENYLALA NINE (fMLP) IN REDUCING PERIPROSTHETIC JOINT INFECTION
J. L. Hamilton et al.
EUROPEAN CELLS & MATERIALS (2021)
Eravacycline for the treatment of complicated intra-abdominal infections
Hongmei Wang et al.
ADVANCES IN DIGESTIVE MEDICINE (2021)
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
Johann Motsch et al.
CLINICAL INFECTIOUS DISEASES (2020)
Alginate Lyase Guided Silver Nanocomposites for Eradicating Pseudomonas aeruginosa from Lungs
Bing Wan et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study
Christian van Delden et al.
CLINICAL INFECTIOUS DISEASES (2020)
Evidence for inoculum size and gas interfaces as critical factors in bacterial biofilm formation on magnesium implants in an animal model
Muhammad Imran Rahim et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Curtailing Quorum Sensing in Pseudomonas aeruginosa by Sitagliptin
Hisham A. Abbas et al.
CURRENT MICROBIOLOGY (2020)
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial
Michael S. Niederman et al.
LANCET INFECTIOUS DISEASES (2020)
Bacterial Pneumonia in Dogs and Cats: An Update
Jonathan D. Dear
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2020)
Systemic infection facilitates transmission of Pseudomonas aeruginosa in mice
Kelly E. R. Bachta et al.
NATURE COMMUNICATIONS (2020)
Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?
Maria Milagro Montero et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Resistance Evolution Against Antimicrobial Peptides in Staphylococcus aureus Alters Pharmacodynamics Beyond the MIC
Baydaa El Shazely et al.
FRONTIERS IN MICROBIOLOGY (2020)
Mechanism of Action of Surface Immobilized Antimicrobial Peptides Against Pseudomonas aeruginosa
Muhammad Yasir et al.
FRONTIERS IN MICROBIOLOGY (2020)
The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry
Iris Xiaoxue Yin et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Prevalence and Some Possible Mechanisms of Colistin Resistance Among Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa
Rehab M. Abd El-Baky et al.
INFECTION AND DRUG RESISTANCE (2020)
Three Year Study of Infection Profile and Antimicrobial Resistance Pattern from Burn Patients in Southwest Iran
Amir Emami et al.
INFECTION AND DRUG RESISTANCE (2020)
The Role of Bacterial Membrane Vesicles in the Dissemination of Antibiotic Resistance and as Promising Carriers for Therapeutic Agent Delivery
Md Jalal Uddin et al.
MICROORGANISMS (2020)
Characterizing the Mechanism of Action of an Ancient Antimicrobial, Manuka Honey, against Pseudomonas aeruginosa Using Modern Transcriptomics
Daniel Bouzo et al.
MSYSTEMS (2020)
Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance
Carole Ayoub Moubareck
MEMBRANES (2020)
Novel therapeutic strategies for treatingPseudomonas aeruginosainfection
Xiaolong Shao et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Bacteriophage therapy againstPseudomonas aeruginosabiofilms: a review
Zahra Chegini et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2020)
Pseudomonas aeruginosa Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France
Matteo Cerioli et al.
FRONTIERS IN MEDICINE (2020)
β-lactam antibiotics: An overview from a medicinal chemistry perspective
Lidia Moreira Lima et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Epidemiology of burn wound bacterial infections at a Meknes hospital, Morocco
N. El Hamzaoui et al.
NEW MICROBES AND NEW INFECTIONS (2020)
Pseudomonas Aeruginosa as the Main Causative Agent of Osteomyelitis and its Susceptibility to Antibiotics
Natalya N. Pliska
DRUG RESEARCH (2020)
Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patients
Elana Shaw et al.
RSC MEDICINAL CHEMISTRY (2020)
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Charles H. Chen et al.
ANTIBIOTICS-BASEL (2020)
A Clinical Review and Critical Evaluation of Imipenem-Relebactam: Evidence to Date
Toni A. Campanella et al.
INFECTION AND DRUG RESISTANCE (2020)
Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review
Athanasios Kakasis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long Is Long Enough?
Valeria Fabre et al.
CLINICAL INFECTIOUS DISEASES (2019)
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
George G. Zhanel et al.
DRUGS (2019)
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
Khalid Eljaaly et al.
DRUGS (2019)
Eravacycline: A Review in Complicated Intra-Abdominal Infections
Lesley J. Scott
DRUGS (2019)
Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients
Signe Agnete Moller et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model
Marco Cafora et al.
SCIENTIFIC REPORTS (2019)
The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program
Daniel J. Diekema et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient
Nancy Law et al.
INFECTION (2019)
Antibiotics versus biofilm: an emerging battleground in microbial communities
Divakar Sharma et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
Prosthetic valve endocarditis caused by Pseudomonas aeruginosa with variable antibacterial resistance profiles: a diagnostic challenge
Nicolas Gurtler et al.
BMC INFECTIOUS DISEASES (2019)
Eravacycline, a newly approved fluorocycline
Young Ran Lee et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Juan P. Horcajada et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical
Luisa Sorli et al.
JOURNAL OF INFECTION (2019)
Pharmacological limitations of phage therapy
Anders S. Nilsson
UPSALA JOURNAL OF MEDICAL SCIENCES (2019)
A BAC Transgene Expressing Human CFTR under Control of Its Regulatory Elements Rescues Cftr Knockout Mice
Lara R. Gawenis et al.
SCIENTIFIC REPORTS (2019)
A novel mouse model for septic arthritis induced by Pseudomonas aeruginosa
Tao Jin et al.
SCIENTIFIC REPORTS (2019)
A Systematic Review of Single-Dose Aminoglycoside Therapy for Urinary Tract Infection: Is It Time To Resurrect an Old Strategy?
Kellie J. Goodlet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
2202. Validation of a Rabbit Model of Pseudomonas aeruginosa Acute Pneumonia
Emmanuelle Gras et al.
Open Forum Infectious Diseases (2019)
Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections
Mohammad Yousef Memar et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Zheng Pang et al.
BIOTECHNOLOGY ADVANCES (2019)
Queensland Microbial Keratitis Database: 2005-2015
Matthew Green et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
The Pseudomonas aeruginosa Pan-Genome Provides New Insights on Its Population Structure, Horizontal Gene Transfer, and Pathogenicity
Luca Freschi et al.
GENOME BIOLOGY AND EVOLUTION (2019)
The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
James Mwangi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Changing drug resistance profile in Pseudomonas aeruginosa infection among HIV patients from 2010-2017: A retrospective study
Chinnambedu Ravichandran Swathirajan et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections
Daniel M. Foulkes et al.
MICROORGANISMS (2019)
Honey can inhibit and eliminate biofilms produced by Pseudomonas aeruginosa
Jing Lu et al.
SCIENTIFIC REPORTS (2019)
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Preeti Pachori et al.
GENES & DISEASES (2019)
Silver in Wound Care-Friend or Foe?: A Comprehensive Review
Ibrahim Khansa et al.
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN (2019)
Antibacterial Potency of Honey
Najla A. Albaridi
INTERNATIONAL JOURNAL OF MICROBIOLOGY (2019)
Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity
Roger L. Nation et al.
ANTIBIOTICS-BASEL (2019)
Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-Generated by Crispr-Cas9
Elise Dreano et al.
ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2019)
Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections
F. Wagenlehner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Negative pressure wound therapy reduces the motility of Pseudomonas aeruginosa and enhances wound healing in a rabbit ear biofilm infection model
Wang Guoqi et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2018)
Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa
Eric R. Ocheretyaner et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)
Stability and low induction propensity of cefiderocol against chromosomal AmpC beta-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae
Akinobu Ito et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Developments in strategies for Quorum Sensing virulence factor inhibition to combat bacterial drug resistance
Shafiul Haque et al.
MICROBIAL PATHOGENESIS (2018)
Antibiotic Prophylaxis in Surgical Sterilization: Following the Recommendations
Kelley T. Saunders et al.
OBSTETRICS AND GYNECOLOGY (2018)
Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections
Nattawan Palavutitotai et al.
PLOS ONE (2018)
Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice
Xiaoli Zhang et al.
VACCINE (2018)
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice
Angela Sandri et al.
VIRULENCE (2018)
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
Gowri Raman et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2018)
Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections
Xiuhong Yuan et al.
INFECTION AND DRUG RESISTANCE (2018)
Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam
Fernando Sanz-Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Recent updates of fluoroquinolones as antibacterial agents
Hend A. A. Ezelarab et al.
ARCHIV DER PHARMAZIE (2018)
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis
Michael D. Parkins et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis
Eliseth Costa Oliveira de Matos et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2018)
Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa
Melissa D. Barnes et al.
MBIO (2018)
Innate antimicrobial immunity in the skin: A protective barrier against bacteria, viruses, and fungi
Margaret Coates et al.
PLOS PATHOGENS (2018)
A sheep model of cystic fibrosis generated by CRISPR/Cas9 disruption of the CFTR gene
Zhiqiang Fan et al.
JCI INSIGHT (2018)
Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective
Dinesh Subedi et al.
CLINICAL AND EXPERIMENTAL OPTOMETRY (2018)
Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms
Yu Mi Wi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Phage treatment of an aortic graft infected with & IT;Pseudomonas aeruginosa & IT;
Benjamin K. Chan et al.
EVOLUTION MEDICINE AND PUBLIC HEALTH (2018)
Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
J. Dobias et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2017)
Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014
Yi Dou et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Neurocognitive Outcomes at 10 Years of Age in Extremely Preterm Newborns with Late-Onset Bacteremia
H. Reeve Bright et al.
JOURNAL OF PEDIATRICS (2017)
American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update
Kristen A. Ban et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2017)
Patent Review of Manufacturing Routes to Fifth-Generation Cephalosporin Drugs. Part 1, Ceftolozane
David L. Hughes
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2017)
Emergence of Antimicrobial Resistance among Pseudomonas aeruginosa: Implications for Therapy
Joseph P. Lynch et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
The use of negative pressure wound therapy to prevent post-operative surgical site infections following pancreaticoduodenectomy
Richard A. Burkhart et al.
HPB (2017)
Bacterial profile of ocular infections: a systematic review
Mebrahtu Teweldemedhin et al.
BMC OPHTHALMOLOGY (2017)
Plazomicin Vs. Meropenem for Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP): Diagnosis-specific Results From the Phase 3 EPIC Study
Daniel J Cloutier et al.
Open Forum Infectious Diseases (2017)
Burn Injury Leads to Increased Long-Term Susceptibility to Respiratory Infection in both Mouse Models and Population Studies
Vanessa S. Fear et al.
PLOS ONE (2017)
Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile
Aubrey Balch et al.
PLOS ONE (2017)
Immune Response and Mortality Risk Relate to Distinct Lung Microbiomes in Patients with HIV and Pneumonia
Meera K. Shenoy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections
John W. Newman et al.
FEMS MICROBIOLOGY LETTERS (2017)
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance
Ghady Haidar et al.
CLINICAL INFECTIOUS DISEASES (2017)
Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria
Joshua T. Thaden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia IASIS Trial
Marin H. Kollef et al.
CHEST (2017)
Nosocomial outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with aromatherapy
Astrid Mayr et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2017)
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Clayton W. Hall et al.
FEMS MICROBIOLOGY REVIEWS (2017)
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
Jordi Rello et al.
CRITICAL CARE (2017)
Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database
Geoffrey L. Winsor et al.
NUCLEIC ACIDS RESEARCH (2016)
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
Christopher Lucasti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa
Akinobu Ito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Epidemiology of hospital-acquired pneumonia: Results of a Central European multicenter, prospective, observational study compared with data from the European region
Tomas Herkel et al.
BIOMEDICAL PAPERS-OLOMOUC (2016)
Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis
Elizabeth L. Salsgiver et al.
CHEST (2016)
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
George G. Zhanel et al.
DRUGS (2016)
Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis
Chengyi Ding et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options
Maitrayee Chatterjee et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Perioperative high inspired oxygen fraction therapy reduces surgical site infection with Pseudomonas aeruginosa in rats
Jeffrey S. Kroin et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Pseudomonas aeruginosa infective endocarditis in patients who do not use intravenous drugs: Analysis of risk factors and treatment outcomes
Ting-I Lin et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery
Jashvant Poeran et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2016)
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
Yehuda Carmeli et al.
LANCET INFECTIOUS DISEASES (2016)
Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients
Carlota Gudiol et al.
RESPIROLOGY (2016)
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
Craig Winstanley et al.
TRENDS IN MICROBIOLOGY (2016)
Targeting the Type Three Secretion System in Pseudomonas aeruginosa
Ahalieyah Anantharajah et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
Katri Korpela et al.
NATURE COMMUNICATIONS (2016)
Bloodstream infections after solid-organ transplantation
Antonios Kritikos et al.
VIRULENCE (2016)
Polymyxin: Alternative Mechanisms of Action and Resistance
Michael J. Trimble et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Tetracycline Antibiotics and Resistance
Trudy H. Grossman
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation
Amy Langdon et al.
GENOME MEDICINE (2016)
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Sirijan Santajit et al.
BIOMED RESEARCH INTERNATIONAL (2016)
A Child With Septic Shock and Purpura
Aisling Flinn et al.
JAMA PEDIATRICS (2016)
Prevalence of multidrug-resistant, extensively drug-resistant, and pandrug-resistant Pseudomonas aeruginosa from a tertiary level Intensive Care Unit
J. S. Gill et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2016)
Short-Term Glycemic Control Is Effective in Reducing Surgical Site Infection in Diabetic Rats
Jeffrey S. Kroin et al.
ANESTHESIA AND ANALGESIA (2015)
Mechanisms of drug resistance: quinolone resistance
David C. Hooper et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS (2015)
Contribution of Stress Responses to Antibiotic Tolerance in Pseudomonas aeruginosa Biofilms
Philip S. Stewart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The analysis of distribution of multidrug resistant Pseudomonas and Bacillus species from burn patients and burn ward environment
Manju Panghal et al.
BURNS (2015)
Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis
Nicole Mayer-Hamblett et al.
CLINICAL INFECTIOUS DISEASES (2015)
The increasing threat of Pseudomonas aeruginosa high-risk clones
Antonio Oliver et al.
DRUG RESISTANCE UPDATES (2015)
Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus
Raffaele Serra et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology
Anais Potron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Bacteremia is associated with excess long-term mortality: A 12-year population-based cohort study
Stig Lonberg Nielsen et al.
JOURNAL OF INFECTION (2015)
Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines
J. Goldufsky et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Clostridium difficile Infection
Daniel A. Leffler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Deficiency of Interleukin-1 Receptor-associated Kinase 4 Presenting as Fatal Pseudomonas aeruginosa Bacteremia in Two Siblings
Theodouli Stergiopoulou et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Acute renal failure after high-dose antibiotic bone cement: case report and review of the literature
Alexia James et al.
RENAL FAILURE (2015)
Pseudomonas aeruginosa: Evolution of Antimicrobial Resistance and Implications for Therapy
Kate McCarthy
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Pseudomonas aeruginosa uses T3SS to inhibit diabetic wound healing
Josef Goldufsky et al.
WOUND REPAIR AND REGENERATION (2015)
Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium
Luca Freschi et al.
FRONTIERS IN MICROBIOLOGY (2015)
The Novel Immunotherapeutic Oligodeoxynucleotide IMT504 Protects Neutropenic Animals from Fatal Pseudomonas aeruginosa Bacteremia and Sepsis
Abdullah Chahin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Unexpected Challenges in Treating Multidrug-Resistant Gram-Negative Bacteria: Resistance to Ceftazidime-Avibactam in Archived Isolates of Pseudomonas aeruginosa
Marisa L. Winkler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011
Xiaoli Zhang et al.
JOURNAL OF ANTIBIOTICS (2015)
Adverse Reactions Associated with Systemic Polymyxin Therapy
Julie Ann Justo et al.
PHARMACOTHERAPY (2015)
What It Takes to Be a Pseudomonas aeruginosa? The Core Genome of the Opportunistic Pathogen Updated
Benoit Valot et al.
PLOS ONE (2015)
Genome Sequences of Three Strains of the Pseudomonas aeruginosa PA7 Clade
Amine M. Boukerb et al.
GENOME ANNOUNCEMENTS (2015)
An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance
Scott T. Micek et al.
CRITICAL CARE (2015)
Metabolomics of Bronchoalveolar Lavage Differentiate Healthy HIV-1-Infected Subjects from Controls
Sushma K. Cribbs et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)
A Novel Porcine Model of Ventilator-associated Pneumonia Caused by Oropharyngeal Challenge with Pseudomonas aeruginosa
Gianluigi Li Bassi et al.
ANESTHESIOLOGY (2014)
A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models
Paul Warrener et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Tetracycline antibiotics and resistance mechanisms
Fabian Nguyen et al.
BIOLOGICAL CHEMISTRY (2014)
An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy
Marta Ciofi degli Atti et al.
BMC INFECTIOUS DISEASES (2014)
A Type III Secretion Negative Clinical Strain of Pseudomonas aeruginosa Employs a Two-Partner Secreted Exolysin to Induce Hemorrhagic Pneumonia
Sylvie Elsen et al.
CELL HOST & MICROBE (2014)
Risk for Myocardial Infarction and Stroke After Community- Acquired Bacteremia A 20-Year Population- Based Cohort Study
Michael Dalager-Pedersen et al.
CIRCULATION (2014)
Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2014)
Innate immune memory: towards a better understanding of host defense mechanisms
Jessica Quintin et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
An analysis of FDA-approved drugs for infectious disease: antibacterial agents
Michael S. Kinch et al.
DRUG DISCOVERY TODAY (2014)
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
Ilias Karaiskos et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
The current spectrum of infection in cancer patients with chemotherapy related neutropenia
Lior Nesher et al.
INFECTION (2014)
Antibiotic resistance in Pseudomonas aeruginosa biofilms: Towards the development of novel anti-biofilm therapies
Patrick K. Taylor et al.
JOURNAL OF BIOTECHNOLOGY (2014)
Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumours
Mar Marin et al.
JOURNAL OF INFECTION (2014)
Ventilator-associated pneumonia after cardiac surgery: A meta-analysis and systematic review
Siyi He et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
Side effects of antibiotics during bacterial infection: Mitochondria, the main target in host cell
Rochika Singh et al.
MITOCHONDRION (2014)
Global antibiotic consumption 2000 to 2010: an analysis of Cross Mark 742 national pharmaceutical sales data
Thomas P. Van Boeckel et al.
LANCET INFECTIOUS DISEASES (2014)
Does Hyperbaric Oxygen Therapy Work in Facilitating Acute Wound Healing: A Systematic Review
Phillip B. Dauwe et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Venous Thromboembolism after Community-Acquired Bacteraemia: A 20-year Danish Cohort Study
Michael Dalager-Pedersen et al.
PLOS ONE (2014)
Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides
Sibel Dosler et al.
PEPTIDES (2014)
Comparative Genomics of Isolates of a Pseudomonas aeruginosa Epidemic Strain Associated with Chronic Lung Infections of Cystic Fibrosis Patients
Julie Jeukens et al.
PLOS ONE (2014)
Negative Pressure Wound Therapy Decreases Mortality in a Murine Model of Burn-Wound Sepsis Involving Pseudomonas aeruginosa Infection
Yang Liu et al.
PLOS ONE (2014)
Pro-Inflammatory Chemokine CCL2 (MCP-1) Promotes Healing in Diabetic Wounds by Restoring the Macrophage Response
Stephen Wood et al.
PLOS ONE (2014)
Neutrophil-Mediated Phagocytic Host Defense Defect in Myeloid Cftr-Inactivated Mice
Hang Pong Ng et al.
PLOS ONE (2014)
MRI Visualization of Staphyloccocus aureus-Induced Infective Endocarditis in Mice
Janine Ring et al.
PLOS ONE (2014)
Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality
Q. F. Ye et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Pseudomonas aeruginosa inhibits the growth of pathogenic fungi: In vitro and in vivo studies
Lingqing Xu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Burn injury, gender and cancer risk: population-based cohort study using data from Scotland and Western Australia
Janine M. Duke et al.
BMJ OPEN (2014)
Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer
Panayiota Markou et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
The role of metabolism in bacterial persistence
Stephanie M. Amato et al.
FRONTIERS IN MICROBIOLOGY (2014)
Responses of Pseudomonas aeruginosa to antimicrobials
Yuji Morita et al.
FRONTIERS IN MICROBIOLOGY (2014)
Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
Dilip Nathwani et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2014)
Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review
Ana Margarida Sousa et al.
PATHOGENS (2014)
Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
J. A. Sutcliffe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients
Mario Tumbarello et al.
INTENSIVE CARE MEDICINE (2013)
Quantitation and Composition of Cutaneous Microbiota in Diabetic and Nondiabetic Men
Henry Redel et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice
Chase Watters et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2013)
Health Care-Associated Infections A Meta-analysis of Costs and Financial Impact on the US Health Care System
Eyal Zimlichman et al.
JAMA INTERNAL MEDICINE (2013)
Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
Shaan L. Gellatly et al.
PATHOGENS AND DISEASE (2013)
The diabetic foot infections: Biofilms and antimicrobial resistance
Abida Malik et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2013)
Hyperbaric oxygen therapy in a mouse model of implant-associated osteomyelitis
Sabrina Shandley et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2012)
Pseudomonas Aeruginosa Urinary Tract Infection in Children: Risk Factors and Outcomes
M. Bitsori et al.
JOURNAL OF UROLOGY (2012)
Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration
Ken Fukuda et al.
PLOS ONE (2012)
Brassinosteroids inhibit pathogen-associated molecular pattern-triggered immune signaling independent of the receptor kinase BAK1
Catherine Albrecht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor
David E. Ehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Role of Innate Immunity in the Host Defense Against Intestinal Bacterial Pathogens
John Sotolongo et al.
CURRENT INFECTIOUS DISEASE REPORTS (2012)
High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia
Doo Ryeon Chung et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Neurotoxic effects associated with antibiotic use: management considerations
Marie F. Grill et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?
P. Ramakant et al.
DIABETOLOGIA (2011)
Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity against Pseudomonas aeruginosa Acute Lung Infection
Akinobu Kamei et al.
INFECTION AND IMMUNITY (2011)
Outbreak of Pseudomonas aeruginosa Surgical Site Infections after Arthroscopic Procedures: Texas, 2009
Pritish K. Tosh et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection
Oscar Cirioni et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
The role of topical antibiotics used as prophylaxis in surgical site infection prevention
S. M. McHugh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Mouse models of cystic fibrosis: Phenotypic analysis and research applications
Martina Wilke et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies
Maarten Fauvart et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Spectrum of Early-Onset and Late-Onset Bacteremias After Liver Transplantation: Implications for Management
Sang-Oh Lee et al.
LIVER TRANSPLANTATION (2011)
Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in pressure ulcer infection in rats
Gojiro Nakagami et al.
WOUND REPAIR AND REGENERATION (2011)
Beta-lactam antibiotics: from antibiosis to resistance and bacteriology
Kok-Fai Kong et al.
APMIS (2010)
Inflammasome Inhibition as a Pathogenic Stealth Mechanism
Debra J. Taxman et al.
CELL HOST & MICROBE (2010)
Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Ronald N. Jones
CLINICAL INFECTIOUS DISEASES (2010)
Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance
Nadine-C. Emrich et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
Pinyo Rattanaumpawan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Capucine Picard et al.
MEDICINE (2010)
Complete Genome Sequence of the Multiresistant Taxonomic Outlier Pseudomonas aeruginosa PA7
Paul H. Roy et al.
PLOS ONE (2010)
Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth
Mark P. Rogan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Nityakalyani Srinivas et al.
SCIENCE (2010)
Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth
David A. Stoltz et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: A clinical trial of immunogenicity in lower airways of human volunteers
Dirk Bumann et al.
VACCINE (2010)
Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds
Ge Zhao et al.
WOUND REPAIR AND REGENERATION (2010)
Pseudomonas pyocyanin inhibits wound repair by inducing premature cellular senescence: Role for p38 mitogen-activated protein kinase
Michael Muller et al.
BURNS (2009)
Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005
Samiya Razvi et al.
CHEST (2009)
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Philip D. Lister et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Role of Pseudomonas aeruginosa type III effectors in disease
Joanne Engel et al.
CURRENT OPINION IN MICROBIOLOGY (2009)
Hyperbaric oxygen therapy as an anti-infective agent
Maide Cimsit et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Standardized antibacterial honey (Medihoney™) with standard therapy in wound care: randomized clinical trial
Val Robson et al.
JOURNAL OF ADVANCED NURSING (2009)
Are pigs more human than mice?
Ronald Oude Elferink et al.
JOURNAL OF HEPATOLOGY (2009)
A murine model of urinary tract infection
Chia-Suei Hung et al.
NATURE PROTOCOLS (2009)
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Alan R. Hauser
NATURE REVIEWS MICROBIOLOGY (2009)
Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients
L. E. Johnson et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP)
Scot E. Dowd et al.
BMC MICROBIOLOGY (2008)
Survey of bacterial diversity in chronic wounds using Pyrosequencing, DGGE, and full ribosome shotgun sequencing
Scot E. Dowd et al.
BMC MICROBIOLOGY (2008)
Skin microbiota: a source of disease or defence?
A. L. Cogen et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: Need for international harmonization in terminology
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Risk factors and causative organisms in microbial keratitis
Matthew Green et al.
CORNEA (2008)
Protective effects of the combination of α-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection
Oscar Cirioni et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets
Xingshen Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Distribution, organization, and ecology of bacteria in chronic wounds
Klaus Kirketerp-Moller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE
Louis B. Rice
JOURNAL OF INFECTIOUS DISEASES (2008)
Why chronic wounds will not heal: a novel hypothesis
Thomas Bjarnsholt et al.
WOUND REPAIR AND REGENERATION (2008)
Biofilms in chronic wounds
Garth A. James et al.
WOUND REPAIR AND REGENERATION (2008)
Viral evasion and subversion of pattern-recognition receptor signalling
Andrew G. Bowie et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome
Fayyaz S. Sutterwala et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Medical progress: Infection in solid-organ transplant recipients
Jay A. Fishman
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Bloodstream infections among transplant recipients:: Results of a nationwide surveillance in Spain
A. Moreno et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Cathelicidin-deficient (Cnlp-/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis
Ling C. Huang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Silver against Pseudomonas aeruginosa biofilms
Thomas Bjarnsholt et al.
APMIS (2007)
Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model
Catherine S. McVay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Rapid and accurate detection of Pseudomonas aeruginosa by real-time polymerase chain reaction with melting curve analysis targeting gyrB gene
Maiko Motoshima et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model
Mary S. F. Kwong et al.
INFECTION AND IMMUNITY (2007)
Polymyxin antibiotics for gram-negative infections
Tamra M. Arnold et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Valid publication of names of prokaryotes according to the rules of nomenclature:: past history and current practice
Brian J. Tindall et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2006)
Bacterial elicitation and evasion of plant innate immunity
Robert B. Abramovitch et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice
AM van Heeckeren et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial
Daniel G. Lee et al.
GENOME BIOLOGY (2006)
Epidemiology and outcomes of health-care-associated pneumonia - Results from a large US database of culture-positive pneumonia
MH Kollef et al.
CHEST (2005)
Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa:: Epidemiology and treatment options
MD Obritsch et al.
PHARMACOTHERAPY (2005)
Bactericidal activity of different honeys against pathogenic bacteria
PE Lusby et al.
ARCHIVES OF MEDICAL RESEARCH (2005)
Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis
C Winstanley et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Pathogen-host interactions in Pseudomonas aeruginosa pneumonia
RT Sadikot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection
S Tal et al.
JOURNAL OF INFECTION (2005)
Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?
KA Brogden
NATURE REVIEWS MICROBIOLOGY (2005)
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the united states today surveillance studies
JA Karlowsky et al.
CLINICAL INFECTIOUS DISEASES (2005)
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis
ZH Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Aminoglycoside resistance in Pseudomonas aeruginosa
K Poole
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Severe Pseudomonas aeruginosa infections - Tackling the conundrum of drug resistance
AR Hauser et al.
POSTGRADUATE MEDICINE (2005)
Neutrophil extracellular traps kill bacteria
V Brinkmann et al.
SCIENCE (2004)
Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections
U Baumann et al.
VACCINE (2004)
Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa
S Osmon et al.
CHEST (2004)
Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management
J Crawford et al.
CANCER (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Neutrophil function in the healing wound: adding insult to injury?
JV Dovi et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms
G Borriello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002
MD Obritsch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Oral vaccination of BALB/c mice with Salmonella enterica serovar typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model
A DiGiandomenico et al.
INFECTION AND IMMUNITY (2004)
The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities
L Garrity-Ryan et al.
INFECTION AND IMMUNITY (2004)
Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously
C Llanes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen
GB Pier
CARBOHYDRATE RESEARCH (2003)
Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers:: comparison of a systemic vs. a mucosal booster schedule
K Göcke et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Antibiotic resistance among gram-negative bacilli in US intensive care units - Implications for fluoroquinolone use
MM Neuhauser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Pseudomonas aeruginosa keratitis in IL-6-deficient mice
N Cole et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2003)
Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care
S Harbarth et al.
ARCHIVES OF SURGERY (2002)
Early infection and progression of cystic fibrosis lung disease
C Koch
PEDIATRIC PULMONOLOGY (2002)
Extrusion of penem antibiotics by multicomponent efflux systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa
K Okamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Murine models of chronic Pseudomonas aeruginosa lung infection
AM van Heeckeren et al.
LABORATORY ANIMALS (2002)
Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics
HK Estahbanati et al.
BURNS (2002)
How do bacteria resist human antimicrobial peptides?
A Peschel
TRENDS IN MICROBIOLOGY (2002)
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
WT Hughes et al.
CLINICAL INFECTIOUS DISEASES (2002)
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
DM Livermore
CLINICAL INFECTIOUS DISEASES (2002)
Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa
AR Hauser et al.
CRITICAL CARE MEDICINE (2002)
Antibiotic resistance of bacteria in biofilms
PS Stewart et al.
LANCET (2001)
Catheter-associated urinary tract infections
JW Warren
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
Pseudomonas aeruginosa ExoT inhibits in vitro lung epithelial wound repair
TK Geiser et al.
CELLULAR MICROBIOLOGY (2001)
Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea
W Song et al.
BURNS (2001)
Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps:: Exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ
R Chuanchuen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers
SO Oyibo et al.
DIABETIC MEDICINE (2001)
Nosocomial infections in an Iranian burn care center
AR Lari et al.
BURNS (2000)
The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa
KP Rumbaugh et al.
MICROBES AND INFECTION (2000)
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
CK Stover et al.
NATURE (2000)
Establishment of Pseudomonas aeruginosa infection:: lessons from a versatile opportunist
JB Lyczak et al.
MICROBES AND INFECTION (2000)
Significance of blood stream infection after lung transplantation: Analysis in 176 consecutive patients
SM Palmer et al.
TRANSPLANTATION (2000)
Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice
H Takase et al.
INFECTION AND IMMUNITY (2000)
Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer -: Retrospective analysis of 245 episodes
I Chatzinikolaou et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Bacterial pneumonia in hospitalized patients with HIV infection - The pulmonary complications, ICU support, and prognostic factors of hospitalized patients with HIV (PIP) study
B Afessa et al.
CHEST (2000)
Pseudomonas spp. complications in patients with HIV disease:: An eight-year clinical and microbiological survey
R Manfredi et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2000)
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
REW Hancock et al.
DRUG RESISTANCE UPDATES (2000)
Share Paper
